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Abstract
Background: Sepsis is a major disease affecting almost all organs and systems.
Objectives: To examine platelet count and indices (mean platelet volume (MPV) and platelet distribution width (PDW))
in severe sepsis.
Methods: Patients with criteria for sepsis at a first examination by an Infectious Diseases specialist were selected. Consecutive
patients who were admitted to the out-patient clinic and who were not diagnosed with any infectious disease were selected
as the control group.
Results: A total of  145 patients with sepsis and 143 patients as a control group were included in the study. MPV and PDW
were significantly differentbetween sepsis patients and control group (P<0.05). Platelet count in sepsis patients was lower
than control group but the difference was not significant. PDW was the unique significantly different parameter between
survivors and non-survivors (p=0.001).
Conclusions: Platelet indices are important laboratory findings in the diagnosis of sepsis and severe sepsis. Severe sepsis
patients who have greater than 18 % PDW levels have a higher risk of  death. Therefore, PDW, which is part of  an
inexpensive, easily accessible and routinely performed test for almost all patients admitted to health facilities may be used for
predicting mortality.
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Introduction
Sepsis is a major disease affecting millions of people
worldwide each year.1 Approximately 750,000 cases
of sepsis per year were seen in the United States
(US), and led to 215,000 death. The economic burden
of this disease for the US was 16.7 billion US dollars/
year2. Almost all organs and systems are affected by
sepsis. The haemostatic system is also adversely
affected.3 In sepsis pathophysiology: clotting cascades
do not function, many pro- and anti-inflammatory
cytokines are released from mononuclear and
endothelial cells, thrombus occurs in later stages, and
plasminogen stimulation and antithrombin-III
activation take place in the fibrinolytic system.4 As a
result, fibrinolytic and fibrinogen substances are
depleted, and formation of  clots and bleeding
associated with disseminated intravascular
coagulation (DIC) occur at the same time. In the
end, DIC results with increased platelet destruction.5,6
There is also peripheral non-immune destruction,
hemophagocytic histiocytosis, and marrow
suppression, all playing different roles in
thrombocytopenia in septic patients.7
The contribution of thrombocytopenia in
severe sepsis has not been clearly established.3,7 The
normal range of  platelet counts in adults is 150,000
– 400,000/µL. Higher platelet counts are observed
in females than in males8. Approximately 40 % of
patients with severe sepsis have platelet counts less
than 80,000/mm3.7   Decreased platelet counts parallel
the severity of infection.9
Mean platelet volume (MPV) is a measurement of
the average size of platelets found in the blood. There
are high MPV levels in destructive thrombocytopenia
and low MPV levels in hypoproliferative
thrombocytopenia10,11. Platelet distribution width
(PDW)  is an indicator of variation in platelet size.
Normal values of  PDW are between 10 % and 17.9
%.12
Easily accessible, inexpensive, and widely used
laboratory tests that show the severity of sepsis are
important. MPV and PDW are widely and routinely
used in clinical practice worldwide. Higher MPV and
increased PDW have been found in sepsis.3 However,
the role of these parameters in severe sepsis have
not been investigated.
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In this study, we aimed to investigate the
relationship between severe sepsis and platelet count,
MPV, and PDW.
Methods
Study design and Setting
This is a retrospective cohort study that was
conducted between September 2011 and May 2012
in a tertiary training and research hospital. Our
hospital consists of two campuses (400 +200 bed
capacity) with a total of 220 doctors, 315 nurses
and 180 auxiliary health personnel. There are two
general intensive care units (ICUs) with 10 and five
beds, one cardiac ICU with six beds, and one
neurological ICU with six beds in our hospital. The
infection control team consists of one Infectious
Diseases and Clinical Microbiology (IDCM) clinical
director, four IDCM specialists and two infection
control nurses.  IDCM specialists and infection
control nurses evaluate the patients in ICU every day
and prescribe their antibiotics.
Study group
Patient medical records and the electronic patient
data monitoring system were examined
retrospectively. Patients diagnosed as sepsis, severe
sepsis, and septic shock at the first medical
examination by an IDCM specialist were included.
Control Group
Control group/patients were selected from
consecutive patients who were admitted to the out-
patient clinic.
Selection criteria for the control group were:
-  no infectious disease diagnosis,
-  normal C-reactive protein (CRP) level in
laboratory examination
- normal leukocyte count in laboratory examination
-  no  systemic inflammatory response syndrome
(SIRS) criteria in his/her medical records
Definitions
The diagnosis of sepsis was made during the first
examination. Sepsis was defined as SIRS with a
proven or suspected source of infection. SIRS was
defined as two or more of the perturbations in table
17. Patients who had organ dysfunction and/or
hypoperfusion abnormalities were defined as severe
sepsis (table 1).1Thrombocytopenia was defined as
a platelet count lower than 150,000/mm3.
Table 1: Criteria of  systemic inflammatory response syndrome and severe sepsis
Systemic inflammatory response syndrome criteria7 Severe sepsis criteria1
1. Temperature  (>38° C or <36° C) 1. Arterial hypoxemia (PaO2/ FiO2 < 300)
2. Heart rate (> 90 beats/minute) 2. Acute oliguria (urine output < 0.5 mL/kg/h for at
least 2 hours)
3. Respiratory rate > 20 breaths/minute or PaCo
2
<32 mmHg 3. Creatinine  (increase > 0.5 mg/dL)
4.  White blood cell count > 12.000 cells/mm3 or < 4000 cells/ 4. Coagulopathy (INR > 1.5 or PTT > 60 sec)
      mm3 or > 10 %  immature band forms 5. Ileus
 6. Thrombocytopenia (platelet count < 100,000 mm3)
 7. Hyperbilirubinemia (bilirubin > 4 mg/dL)
Demographic characteristics
Demographic characteristics, such as age, gender, and
the reason for hospitalization (medical or surgical)
and laboratory results (whole blood count and CRP)
at admission were obtained from patient files. Also,
patient files were investigated for 28-day mortality.
Patients who were discharged within 28 days after
diagnosis of sepsis and who continued to have
follow-up in the hospital at the 28th day of patient
monitoring were accepted as survivors.  Patients who
died within the 28 days of patient monitoring were
accepted as non-survivors.
Statistical methods
The Kolmogorov-Smirnov test was used to evaluate
whether the distribution of  variables were normal.
Two independent sample t test was used to compare
the normal distributed continuous variables between
groups. Normal distributed continuous variables
were presented as mean ±standard deviation. Mann-
Whitney U test was used to compare the non-normal
distributed continuous variables between groups.
Non-normal distributed continuous variables were
presented as the median and interquartile range (IQR,
quartile 1 to 3). Categorical variables were compared
by Pearson’s or Yates corrected Chi-Square tests.
Categorical variables were presented as a count and
percentage.
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Receiver operating characteristic (ROC) curve analysis
was performed to establish the most accurate
diagnostic method (biomarker) to discriminate
between sepsis and normal. ROC curves were
constructed for Platelet, mean platelet volume and
platelet distribution Width to test the various
biomarkers in predicting sepsis (figure1). The areas
under the ROC curves (AUC) were calculated and
the specificity, sensitivity, positive-predictive value
(PPV), negative-predictive value (NPV), and accuracy,
for the platelet, mean platelet volume and platelet
distribution Width of the most appropriate cut-off
point were calculated for predicting sepsis. A
multivariate logistic regression model was
implemented to determine Platelet, Mean Platelet
volume and Platelet distribution Width and other
covariates associated with sepsis. A p-value <0.05
was considered significant. Analyses were performed
using commercial software (IBM SPSS Statistics 20,
SPSS inc., IBM Co., Somers, NY; MedCalc11,
Mariakerke, Belgium).
Figure 1: Receiver operating characteristic (ROC) curves for measurements of  Platelet, Mean Platelet
Volume, and Platelet Distribution Width to detect sepsis
Results
A total of 145 sepsis patients were included in this
study. The study population consisted of  61 females
and 84 males, of which 22 were surgical and 123
medical patients. Also, 143 patients (49 females and
94 males) were included as a control group.
Thrombocytopenia was observed in 49 (33.8 %)
patients with sepsis and in 4 (2.8 %) patients in the
control group (p<0.001). Age and gender were
statistically similar between septic patients and the
control group (p>0.05). However, a statistically
significant difference was found in MPV and PDW
Out of 145 sepsis patients, 88 (60.7%) of them were
diagnosed as having severe sepsis.
Thrombocytopenia was observed in 36 (40.9 %)
severe sepsis patients and in 13 (22.8 %) non-severe
sepsis patients (p=0.01). While a statistical difference
was not found between sepsis and severe sepsis
patients in terms of  demographic characteristics,
CRP, leukocyte, and neutrophil count, there was a
meaningful statistical difference in platelet count and
their indices as indicated in table 3.
Table 2: Demographic characteristics and laboratory findings of  patients with sepsis and control
groups
Characteristics Patients with Control group       p value
sepsis(n=145 (n=143)
Gender (Male) 84 (57.9) 94 (65.7) 0.173
Age     (years) 69,0 [49.5-78,0] 62,0 [55,0-73,0] 0.784
Platelet   (K/uL)5 228000 ± 133000 246000 ± 67000 0.148
Mean Platelet Volume (fl)3 8.4 ± 1.7 7.1 ± 1,0 <0.001
Platelet Distribution Width (%)4 18,2 [17,5-19,1] 17,3 [16,9-17,9] <0.001
Data were shown as mean ±standard deviation,median [IQR] and n (%)
between patients with sepsis and the control group
(table 2)(p<0.05).
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Table 3: Demographic and laboratory findings of  patients with sepsis and severe sepsis
Characteristics Patients with sepsis Patients with severe sepsis p value
(N=57) (N=88)
Gender (Male) 34 (59.6) 50 (56.8) 0.869
Age (years) 62.2 ± 20.1 63.1 ± 17.6 0.788
C-Reactive Protein  (mg/L) 150,0 [47,0-230,5] 144 [62,8-278,3] 0.838
Leukocyte   (K/uL) 13700 ± 8050 14200 ± 8900 0.742
Neutrophil   (K/uL) 11650 ± 7780 12200 ± 8410 0.683
Platelet   (K/uL) 264000 ± 129100 204500 ± 130800 0.008
Mean Platelet Volume (fl) 7,0 [7,0-8,0] 8,0 [7,0-9,0] 0.001
Platelet Distribution Width (%) 17,0 [17,0-18,5] 18,0 [17,0-19,0] 0.030
Data were shown as mean ±standard deviation, median [IQR] and n (%).
Among the 145 sepsis patients, 51 (35.2 %) of them
died within the 28-day follow-up.
Thrombocytopenia was observed in 19 (37.3 %)
of  the non-survivors and in 30 (31.9 %) of  the
survivors (p=0.51). There was no statistical difference
between survivors and non-survivors in terms of
demographic characteristics and laboratory findings,
except for PDW. PDW in non-survivors was
significantly higher than in survivors (p=0.001).
Demographic characteristics and laboratory findings
of  survivors and non-survivors are seen in table 4.
MPV levels higher than 8 fl have 53.47 %
sensitivity and 87.41% specifity for sepsis diagnosis.
The results of  ROC curve analysis are shown in table
5. On multivariate analysis, the significant independent
risk factors for sepsis were age, MPV, and PDW
(table 6).
Table 4:  Characteristics of  sepsis patients who did or did not survive within the 28-day follow-
up
Characteristics Survivor(n=51) Non-survivor p value
(n=94)
Gender (Male) 29 (56.9) 55 (58.5) 0.84
Age (years) 66.5 ± 18.5 60.7±18.5 0.073
C-Reactive Protein  (mg/L) 185.7±137.2 178.2±132.5 0.298
Leukocyte   (K/uL) 13700±7980 14100±8860 0.763
Neutrophil   (K/uL) 12200±7670 11900±8430 0.841
Platelet   (K/uL) 201400±102700 242250±145200 0.051
Mean Platelet Volume (fl) 8,0 [7,0-9,0] 7,0 [7,0-9,0] 0.114
Platelet Distribution Width (%) 18,0 [17,0-19,0] 18,0 [17,0-18,0] 0.001
Data were shown as mean ±standard deviation, median [IQR] and n (%).
Table 5: Results of  ROC analysis  for  various  biomarkers in predicting sepsis compared to
control
 Cut-off   Sensitivity   Specificity   Positive  Negative      AUC  CI 95%
              point             Predictive Predictiveof          AUC
                                Value         Value
Platelet   (K/uL)              <=155     35.86              95.80           89.7            59.6      0.599     0.540-
     0.656
Mean Platelet Volume (fl) >8         53.47              87.41           81.1            65.1      0.752     0.698-
      0.801
Plateletdistribution Width (%)>17.9    59.31               76.22           71.7            64.9      0.733      0.678-
      0.783
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Table 6: A multivariate logistic regression model of  biomarkers and other covariates associated
with sepsis
Independent variables â SE of â p OR       95% CI for OR
              Lower   Upper
Gender (Female) -0,206          0,288 0,474       0,814      0,463 1,430
Age (years)    -0,019            0,009               0,041        0,981      0,963 0,999
Leukocyte (K/uL)                0,003             0,001               0,057        1,003      1,000            1,005
Mean Platelet Volume (fl)     0,722           0,150             <0,001        2,059      1,534  2,764
Platelet Distribution Width (%) 0,611           0,167              <0,001 1,843       1,327       2,559
â: Regression coefficient, SE: Standard error,OR: Odds Ratio, CI: confidence interval
 
Discussion
Our findings revealed that MPV and PDW were
significant parameters in septic patients. These
parameters were higher in septic patients than in
controls. In addition, a lower platelet count was
observed in septic patients. This situation was due
to production of many cytokines, endothelial
damage, and bone marrow suppression in septic
patients.
Our findings indicated that greater MPV levels higher
than 8 fl have moderate (53.47 %) sensitivity and
good (87.41%) specificity for sepsis diagnosis.
Therefore, MPV may be used as an auxiliary test in
the diagnosis of  sepsis. A high positive predictive
value of this test (81.1 %) supports this hypothesis
too. Moreover, in multivariate logistic regression
analysis, the independent laboratory parameters in
sepsis diagnosis were MPV [OR:2,05 (1,5 – 2,7)],
and PDW [OR:1,8 (1,3 – 2,5)].
Patients with severe sepsis have lower platelet
count, higher MPV, and increased PDW compared
to patients with sepsis. On the other hand, leukocyte
count, neutrophil count and CRP are not useful in a
differential diagnosis of  sepsis and severe sepsis.
Therefore, platelet count and their indices can be
used as a direct indicator of organ dysfunction.
Findings in a recent study support our results. In that
study, low platelet count was found in the first three
days of Gram-positive septic patients and in the first
four days of  Gram-negative sepsis. Similarly, MPV
was found to be higher in the first three and five
days of Gram-positive sepsis and Gram-negative
sepsis, respectively.13 However, PDW was not
reported in that study. In an animal-experiment study,
researchers found that PDW was increased in the
presence of endotoxemia.14 In a study conducted in
newborns, Patrick et al reported that high levels of
MPV and PDW have 95 % and 79 % specificity in
the detection of  bacteremia, respectively.15
The present study conducted in adults
demonstrated that PDW was higher in sepsis
patients, as were MPV levels. Moreover, PDW and
MPV levels in severe sepsis patients were higher than
in patients with sepsis. It has been demonstrated that
coagulation and platelet activation/hyper aggregation
can occur in an early phase of  sepsis.3 In order to
obtain a larger surface, platelets change their discoid
shape to a spherical shape during activation. At the
same time, pseudopodia formation occurs. Platelets
with increased number and size of pseudopodia may
affect the PDW.16 Platelet volume is related to platelet
function and activation as well. Generally, platelet
production increases as platelet count decreases. An
increased number of young platelets is also
functionally more active than older platelets.17 The
low level of thrombocytopenia in patients with
severe sepsis can explain the high levels of MPV
and PDW.
PDW was the only significant distinctive
laboratory parameter different between survivors
and non-survivors. The threshold of  PDW in
estimating death was 18 %. Septic patients who have
greater than 18 % PDW have a higher risk of death.
In a study that examined 13,701 healthy adults in the
United States, among the platelet indices, only PDW,
and not platelet count or MPV was found to be an
independent predictor of all-cause and cardiovascular
mortality.18 Hence PDW can be used as a parameter
in estimating death rate among septic patients.
Conclusion
MPV and PDW are significant parameters in the
diagnosis of sepsis and in the differential diagnosis
of  sepsis and severe sepsis. PDW is an important
parameter for estimating the death rate among septic
patients.  MPV and PDW values in whole blood
counts, which is performed for almost all patients
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admitted to health facilities, should be carefully
monitored in patients with sepsis.
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